1. Home
  2. ABEO vs FTW Comparison

ABEO vs FTW Comparison

Compare ABEO & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$4.35

Market Cap

282.5M

Sector

Health Care

ML Signal

N/A

Logo EQV Ventures Acquisition Corp. Class A Ordinary Shares

FTW

EQV Ventures Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.26

Market Cap

283.9M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
ABEO
FTW
Founded
1974
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
282.5M
283.9M
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
ABEO
FTW
Price
$4.35
$10.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
★ $18.88
$15.00
AVG Volume (30 Days)
★ 1.0M
86.0K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
★ 13.12%
EPS Growth
★ 165.16
N/A
EPS
N/A
★ N/A
Revenue
★ $2,998,000.00
N/A
Revenue This Year
$804.33
$32.44
Revenue Next Year
$119.68
$3.93
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 258.18
N/A
52 Week Low
$4.00
$9.46
52 Week High
$7.65
$17.20

Technical Indicators

Market Signals
Indicator
ABEO
FTW
Relative Strength Index (RSI) 35.92 50.68
Support Level $4.27 $9.99
Resistance Level $5.91 $10.39
Average True Range (ATR) 0.23 0.20
MACD 0.03 0.06
Stochastic Oscillator 10.83 49.32

Price Performance

Historical Comparison
ABEO
FTW

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About FTW EQV Ventures Acquisition Corp. Class A Ordinary Shares

Presidio Production Co is an independent oil and natural gas company engaged in oil and gas exploration and production, with operations concentrated across the Western Anadarko Basin of Texas, Oklahoma, and Kansas. It oeprates in one reportable segment, which is engaged in the acquisition, development, exploration, and production of oil and natural gas properties. It derives its revenue from customers through the sale of oil, natural gas, and NGLs as well as other immaterial service contracts in United States.

Share on Social Networks: